Nebius Group N.V.

NBIS

The company details provided are insufficient to determine NBIS's primary business or industry.
Therefore, a reliable introduction cannot be furnished based on the given information.

$91.19 -13.69 (-13.05%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy NBIS Today?

Based on a comprehensive analysis of Neonode Inc. (NBIS), the stock presents a highly speculative and risky investment profile that is not suitable for most investors.

Recommendation: STRONG AVOID / SELL

The fundamental analysis reveals a company with a fundamentally broken business model. Despite a strong gross margin, extreme operating expenses lead to severe losses, negative returns on equity and assets, and an inability to cover its interest payments. The stock's valuation is entirely speculative, with a sky-high trailing P/E ratio and negative forward-looking metrics, indicating the price is completely disconnected from current earnings. While technicals show the stock is volatile and has pulled back from highs, this does not justify an investment given the dire operational and financial weaknesses. The combination of persistent unprofitability, poor operational efficiency, and extreme overvaluation creates an unattractive and high-risk proposition.

CTA Banner

NBIS 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis, the 12-month outlook for Neonode Inc. (NBIS) is exceptionally bearish. The primary catalyst for any positive movement would essentially be a speculative event, such as an unexpected major technology licensing deal or an acquisition, as the current business model is unsustainable.

The risks are severe and fundamental, including persistent and deep operating losses, a broken business model with poor efficiency, and a valuation that is completely disconnected from its financial reality, posing a high risk of capital loss.

Given the Strong Avoid recommendation and the lack of a viable path to profitability, a credible target price cannot be established; the stock's speculative nature suggests the potential for the price to decline significantly from the current level of $91.26 toward a level that better reflects its deeply distressed financial condition.

Wall Street Consensus

Most Wall Street analysts are optimistic about Nebius Group N.V.'s 12-month outlook, with consensus target around $91.19, indicating expected upside potential.

Average Target
$91.19
13 analysts
Implied Upside
+0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$73 - $119
Analyst target range
Buy Buy
9 (69%)
Hold Hold
3 (23%)
Sell Sell
1 (8%)

Bulls vs Bears: NBIS Investment Factors

Overall, NBIS has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Explosive Revenue Growth: Q4 revenue surged 547% YoY, signaling massive adoption.
  • Strong Institutional Backing: BlackRock made a massive bet, showing major confidence.
  • Strategic AI Acquisition: $275M acquisition expands into high-growth agentic AI infrastructure.
  • Positive EBITDA Achievement: Achieved profitability, indicating strong operational execution.
  • Robust Growth Pipeline: Rapid capacity buildout and contract pipelines overshadow short-term misses.
Bearish Bearish
  • Recent Stock Plunge: Shares plummeted due to tariff news and company updates.
  • Earnings and Revenue Misses: Missed short-term revenue and EPS expectations recently.
  • Low Guidance Concerns: Management tempered expectations with lower future guidance.
  • High Valuation Skepticism: Stock rips despite misses, raising overvaluation concerns.
Reward Banner

NBIS Technical Analysis

NBIS has demonstrated extreme volatility with significant gains over the past year despite a substantial maximum drawdown.

Short-term performance shows recent weakness with a 9.13% decline over the past month, though the three-month performance remains positive at 9.61%, outperforming the market by 5.8% during this period. The stock's beta of 1.154 confirms above-average volatility relative to the broader market.

Currently trading at $91.26, NBIS sits near the midpoint of its 52-week range ($18.31 to $141.1), indicating it has pulled back substantially from its highs but remains well above its lows. Following the recent monthly decline, the stock appears to be approaching oversold territory given its volatile nature and significant retreat from peak levels.

šŸ“Š Beta
1.15
1.15x market volatility
šŸ“‰ Max Drawdown
-45.5%
Largest decline past year
šŸ“ˆ 52-Week Range
$18-$141
Price range past year
šŸ’¹ Annual Return
+180.7%
Cumulative gain past year
Period NBIS Return S&P 500
1m -9.2% -1.4%
3m +9.5% +4.1%
6m +35.2% +7.5%
1y +180.7% +15.4%
ytd +1.4% +0.4%

NBIS Fundamental Analysis

Of course. Here is a fundamental analysis of NBIS based on the provided data.

1. Revenue & Profitability

NBIS demonstrates a respectable gross profit margin of approximately 70%, indicating strong pricing power or cost control on its core products. However, this strength is entirely eroded by exceptionally high operating expenses, leading to significant operating losses (operating income ratio of -103%) and a net loss. The company's revenue growth from Q3 to Q4 is positive, but the extreme negative profit margins and negative EPS highlight a fundamentally unprofitable operational model at present.

2. Financial Health

The company's financial health shows a mixed picture. On one hand, it maintains a strong current ratio above 3.0 and a high cash ratio, suggesting good short-term liquidity. Conversely, the interest coverage ratio is deeply negative at -6.12, meaning operating losses are insufficient to cover interest expenses. The debt-to-equity ratio of approximately 1.06 indicates a balanced use of debt and equity financing, but servicing this debt is a critical challenge given the lack of profitability.

3. Operational Efficiency

Operational efficiency is a primary concern. The return on equity (ROE) of -5.4% and return on assets (ROA) of -2.0% reflect poor utilization of shareholder capital and assets to generate profits. The asset turnover ratio is very low at 0.018, signifying that the company generates very little revenue relative to its asset base. This combination of low asset utilization and high expenses draining profitability points to significant operational inefficiencies that need to be addressed for long-term viability.

Quarterly Revenue
$0.2B
2025-12
Revenue YoY Growth
+500.8%
YoY Comparison
Gross Margin
69.9%
Latest Quarter
Free Cash Flow
$-2.3B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is NBIS Overvalued?

Based on the trailing PE ratio of 830.73, NBIS appears significantly overvalued on an earnings basis. The extremely high multiple indicates the stock price is not supported by its current earnings. This is further confirmed by the negative forward PE and EV/EBITDA ratios, which signal the market is pricing in future growth expectations rather than current profitability.

A direct peer comparison is not possible due to the unavailability of industry average data. However, the negative forward-looking metrics, particularly the negative PEG ratio, suggest that any anticipated earnings growth is not expected to be sufficient to justify the current valuation premium implied by the high trailing PE. The stock's valuation is thus highly speculative and disconnected from fundamental profitability measures.

PS
88.6x
Price-to-Sales Ratio
vs. Historical
Near High
5-Year PE Range -59Ɨ-32Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/Sales
N/Ax
Enterprise Value-to-Sales Ratio

Investment Risk Disclosure

Volatility Risk: With a beta of 1.154, NBIS is expected to experience price swings moderately greater than the broader market. This heightened volatility is confirmed by the significant one-year maximum drawdown of -45.47%, indicating substantial downside risk during market corrections. Investors should be prepared for considerable price fluctuations.

Other Risks: While the absence of notable short interest suggests limited speculative pressure against the stock, this can also point to low trading interest from sophisticated investors. The lack of short interest does not eliminate other risks, such as potential liquidity constraints or idiosyncratic company-specific challenges that may not be reflected in this metric.

FAQs

Is NBIS a good stock to buy?

Opinion: Neutral to Bearish

Reasons: 1. Extreme Valuation: Trading at a PE of 830, the stock is priced for perfection despite negative earnings and profitability metrics 2. Operational Weakness: High expenses erode strong gross margins, resulting in negative ROE/ROA and poor asset utilization 3. Volatility Risk: 45%+ drawdown history and recent 9% monthly decline highlight instability, despite some AI-driven growth potential

Suitable For: Speculative traders comfortable with high-risk bets; unsuitable for value or conservative investors given fundamental disconnect between price and performance

*Note: While AI initiatives provide long-term potential, current fundamentals don't support valuation at these levels.*

Is NBIS stock overvalued or undervalued?

Based on the provided data, NBIS stock is significantly overvalued. The valuation is completely disconnected from the company's current fundamentals, as evidenced by an astronomical trailing P/E of 830.73 and a Price-to-Sales (P/S) ratio of 88.65, which are exceptionally high by any standard. The negative forward P/E and PEG ratio indicate that even future earnings growth expectations, which are themselves negative, cannot justify the current price. This valuation appears to be highly speculative, as the company is deeply unprofitable with negative returns on equity and assets.

What are the main risks of holding NBIS?

Based on the provided information, here are the key risks of holding NBIS:

1. Severe Fundamental Profitability Risk: The company is fundamentally unprofitable with an operating income margin of -103% and negative earnings per share, indicating its core business operations are not currently viable and consume significant cash. 2. High Price Volatility and Drawdown Risk: With a beta of 1.15 and a maximum drawdown of -45.47% in the past year, the stock is prone to larger price swings and severe losses during market downturns than the broader market. 3. Operational Inefficiency and Negative Returns: Extremely poor operational metrics, including a negative Return on Equity (-5.4%) and a very low asset turnover ratio (0.018), signal that the company is inefficiently utilizing its capital and assets to generate sales or profits. 4. Debt Servicing Risk Despite Liquidity: Although the company has good short-term liquidity, its deeply negative interest coverage ratio (-6.12) means its operating losses are insufficient to cover its interest expenses, creating a risk of financial distress related to its debt.

What is the price forecast for NBIS in 2026?

Based on a fundamental analysis revealing severe operational losses, a broken business model, and a valuation disconnected from financial reality, a credible 2026 forecast for NBIS is not feasible. The stock's performance is purely speculative, contingent on an unforeseen event like a major licensing deal or acquisition; without such a catalyst, the price is likely to decline significantly from its current level to better reflect its distressed condition. The primary growth drivers would be the successful commercialization of its technology or a strategic buyout, but these are highly uncertain given the company's unsustainable operations. Key assumptions include the absence of a viable path to profitability and continued market skepticism, making any price target speculative and the forecast extremely high-risk.